Hemrajani Rekha's Form 4 filing
BioAge Labs, Inc. (BIOA) · filed Sep 27, 2024
- Accession no.
- 0001415889-24-024043
- Filed
- Sep 27, 2024
- Trade date
- Apr 17-Sep 25, 2024
- Filing delay
- 163 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 0 non-derivative transactions and 2 derivative transactions. It was filed 163 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001415889-25-007506 (Mar 10, 2025). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hemrajani RekhaCIK 0001771213 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Common Stock | AGrant or awardAcquired | +15,000 | $0.00 | $0 | 15,000 | Direct | |
| Apr 17, 2024 | Common Stock | AGrant or awardAcquired | +28,497 | $0.00 | $0 | 28,497 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.